Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor
Brad P. Barnett,1,2,*
Yousang Hwang,1,*
Martin S. Taylor,1,2,*
Henriette Kirchner,3,7
Paul T. Pfluger,3
Vincent Bernard,2
Yu-yi Lin,2,6
Erin M. Bowers,1
Chandrani Mukherjee,1
Woo-Jin Song,4
Patti A. Longo,5
Daniel J. Leahy,5
Mehboob A. Hussain,4
Matthias H. Tschöp,3,7
Jef D. Boeke,2,
Philip A. Cole1,,
Abstract:
Ghrelin is a gastric peptide hormone that stimulates weightgain in vertebrates. The biological activities of ghrelin requireoctanoylation of the peptide on Ser3, an unusual posttranslationalmodification that is catalyzed by the enzyme ghrelin O-acyltransferase(GOAT). Here, we describe the design, synthesis, and characterizationof GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizesGOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in culturedcells, and in mice. Intraperitoneal administration of GO-CoA-Tatimproves glucose tolerance and reduces weight gain in wild-typemice but not in ghrelin-deficient mice, supporting the conceptthat its beneficial metabolic effects are due specifically toGOAT inhibition. In addition to serving as a research tool formapping ghrelin actions, GO-CoA-Tat may help pave the way forclinical targeting of GOAT in metabolic diseases.
1 Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 2 Department of Molecular Biology and Genetics and High Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 3 Obesity Research Center, Metabolic Diseases Institute, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45237, USA. 4 Metabolism Division, Departments of Pediatrics, Medicine, and Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 5 Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 6 Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan. 7 Department of Pharmacology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany.
* These authors contributed equally to this work.
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: pcole{at}jhmi.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (21 December 2010) Sci. Signal.3 (153), ec390.
[DOI: 10.1126/scisignal.3153ec390] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis.
P. J. D. Delhanty, M. Huisman, L. Y. Baldeon-Rojas, I. van den Berge, A. Grefhorst, T. Abribat, P. J. M. Leenen, A. P. N. Themmen, and A.-J. van der Lely (2013)
FASEB J
27, 1690-1700
|Abstract »|Full Text »|PDF »
Calorie-Restricted Weight Loss Reverses High-Fat Diet-Induced Ghrelin Resistance, Which Contributes to Rebound Weight Gain in a Ghrelin-Dependent Manner.
D. I. Briggs, S. H. Lockie, Q. Wu, M. B. Lemus, R. Stark, and Z. B. Andrews (2013)
Endocrinology
154, 709-717
|Abstract »|Full Text »|PDF »
MECHANISMS IN ENDOCRINOLOGY: Ghrelin: the differences between acyl- and des-acyl ghrelin.
P. J. D. Delhanty, S. J. Neggers, and A. J. van der Lely (2012)
Eur. J. Endocrinol.
167, 601-608
|Abstract »|Full Text »|PDF »
Vertical Sleeve Gastrectomy Improves Glucose and Lipid Metabolism and Delays Diabetes Onset in UCD-T2DM Rats.
B. P. Cummings, A. Bettaieb, J. L. Graham, K. L. Stanhope, M. Kowala, F. G. Haj, M. L. Chouinard, and P. J. Havel (2012)
Endocrinology
153, 3620-3632
|Abstract »|Full Text »|PDF »
Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans.
A. Benso, D. H. St-Pierre, F. Prodam, E. Gramaglia, R. Granata, A. J. van der Lely, E. Ghigo, and F. Broglio (2012)
Eur. J. Endocrinol.
166, 911-916
|Abstract »|Full Text »|PDF »
Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption.
K. Kang, J. Schmahl, J.-M. Lee, K. Garcia, K. Patil, A. Chen, M. Keene, A. Murphy, and M. W. Sleeman (2012)
FASEB J
26, 259-271
|Abstract »|Full Text »|PDF »
Ghrelin Attenuates cAMP-PKA Signaling to Evoke Insulinostatic Cascade in Islet {beta}-Cells.
K. Dezaki, B. Damdindorj, H. Sone, O. Dyachok, A. Tengholm, E. Gylfe, T. Kurashina, M. Yoshida, M. Kakei, and T. Yada (2011)
Diabetes
60, 2315-2324
|Abstract »|Full Text »|PDF »